ctDNA and tumor-based biomarkers of giredestrant response in acelERA breast cancer

By afschroeder • March 13, 2026

Collier AE, Hilz S, Chibly AM, Duan C, Pasquina LW, Sun X, Chavez-MacGregor M, Bardia A, Martín M, Lim E, Sohn J, Pérez-Moreno PD, Fernando TM, Moore HM. ctDNA and tumor-based biomarkers of giredestrant response in acelERA breast cancer. Nat Commun. 2026 Mar 12. doi: 10.1038/s41467-026-70335-0. Epub ahead of print. PMID: 41820395.

Tags: Hematology/Oncology, Publications

Early detection and localization of recurrent prostate cancer using [Formula: see text]F-DCFPyL PET/CT in patients with low and ultra-low PSA levels

Sonni I, Gulpe A, Nickols NG, Schaffer D, Montagut L, Berenji GR, Rettig MB. Early detection and localization of recurrent prostate cancer using [Formula: see[...]

Lung Cancer Screening in California and Los Angeles County: A Landscape Analysis

Tupper HI, Gao YA, Cummings AL. Lung Cancer Screening in California and Los Angeles County: A Landscape Analysis. Cureus. 2026 Jun 27;18(6):e111619. doi: 10.7759/cureus.111619. PMID:[...]

Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor-positive HER2-negative breast cancer: safety and patient-reported outcomes from the phase III TROPION-Breast01 study

Rugo HS, Jhaveri K, Pernas S, Pistilli B, Im SA, De Laurentiis M, Wang S, Martínez Jañez N, Borges G, Cescon DW, Hattori M, Lu[...]